Home › NDC Lookup › J-codes › J1410
J1410

J1410 – Injection, estrogen conjugated, per 25 mg · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 1 NDC crosswalked per 25 MG $401.503/unit ASP+6%

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

📋 J1410 summary

J1410 is a HCPCS Level II J-code used to bill estrogen conjugated, per 25 mg, billed per 25 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J1410: Premarin

Code J1410 Billing unit 25 MG Payment limit $401.503/unit NDC-Crosswalk 1 Quarter Q3 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ1410
DescriptorInjection, estrogen conjugated, per 25 mg
Billing unit25 MG
Payment limit / unit$401.503
Est. ASP / unit$378.776 est.
Mapped NDCs1
Data periodQ3 2026
Last updated2026-08-20

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026

📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$401.503
Est. ASP / unit
$378.776 est.
Est. after 2% sequester
$393.473
HCPCS dosage
25 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, estrogen conjugated, per 25 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2017-01-01
Date added1982-01-01
Source: CMS HCPCS Level II code file (imported via admin).

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J1410 = 25 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J1410 WITH EST. MEDICARE PAY

1 NDC map to J1410. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($401.503/unit) × that package's bill units.
NDC (11-digit)DrugLabelerPackageStrength Bill units Est. pay / pkg NADAC / unit StatusSource
00046-0749-05 Premarin CONJUGATED ESTROGENS 25 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Wyeth 1 VIAL in 1 CARTON (0046-0749-05) / 5 mL... 25 mg/5mL 1 $401.50 — ● Active CMS + PDAC
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)

Period
Total Part B spend
$6.2K
Claims
44
Beneficiaries
41
Spend / beneficiary
$151.25
Spend / claim
$140.93
Trend by period
Where J1410 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #703 of 824
#698 ARGATROBAN-0.9% NACL... J0883 $6.7K #699 DIHYDROERGOTAMINE ME... J1110 $6.5K #700 PROGRAF(J7525)* J7525 $6.4K #701 IBANDRONATE SODIUM J1740 $6.3K #702 LEVOLEUCOVORIN CALCI... J0641 $6.2K #703 PREMARIN J1410 $6.2K #704 ORPHENADRINE CITRATE J2360 $6.1K #705 HYLENEX J3473 $6K #706 NOVACHOR 1 SQ CM** Q4194 $5.7K #707 MITOXANTRONE HCL J9293 $5.6K #708 NEBUPENT(J2516)* J2516 $5.4K
Total claims — #704 of 824
#699 ENVERSE, PER SQ CM** Q4258 47 #700 COMIRNATY (5-11Y)* 91319 46 #701 AZMIRO J1072 46 #702 AMPHADASE J3470 45 #703 MYLOTARG J9203 45 #704 PREMARIN J1410 44 #705 DERM-MAXX, PER SQ CM... Q4238 44 #706 ABILIFY ASIMTUFII J0402 43 #707 COMPLETE AA, PER SQ... Q4303 43 #708 AZACTAM* J0457 42 #709 BERINERT J0597 42

Full breakdown by period (2)
PeriodTotal spendBeneficiariesClaims$/beneficiary$/claim
2026 (Q1) $6.2K 41 44 $151.25 $140.93
2025 (Q1-Q4) $27.2K 99 209 $275.20 $130.36
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$21.4K
Medicare paid
$15.9K
Submitted services
425
Denial rate
16.9%
Allowed / service
$60.57
Submitted charges
$25.8K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

🗺️ Where J1410 is utilized

⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.

📊 What bills under J1410

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient
CONJUGATED ESTROGENS 1
NDC products by labeler
Wyeth Pharmaceuticals LLC, a subsi... 1

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
1 NDC mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J1410 billing FAQ

What is HCPCS code J1410?
J1410 is a HCPCS Level II J-code used to bill Injection, estrogen conjugated, per 25 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J1410?
One unit of J1410 represents 25 MG. Report the number of units equal to the dose administered divided by 25 MG.
How many units of J1410 should I bill?
Divide the dose administered by the code's unit size (25 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J1410?
The Medicare Part B payment limit is $401.503 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $393.473 per unit. Payment limits are revised quarterly.
Which NDCs bill under J1410?
1 NDC currently map to J1410 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J1410 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.